Login / Signup

The Legacy Effect in Treating Hypercholesterolemia.

John B KostisMrinali ShettyYuvraj Singh ChowdhuryWilliam J Kostis
Published in: Journal of cardiovascular pharmacology and therapeutics (2020)
The legacy effect results in significant long-term clinical benefits by preventing fatal and nonfatal events. This implies that early therapy would result in lower event rates. Long-term follow-up should be a part of clinical trial design in order to evaluate the presence or absence of a legacy effect.
Keyphrases
  • clinical trial
  • stem cells
  • coronary artery disease
  • open label
  • mesenchymal stem cells
  • cardiovascular events
  • double blind